Avacta Group (OTCMKTS:AVCTF) Trading Up 3% – What’s Next?

Avacta Group Plc (OTCMKTS:AVCTF) shot up 3% during trading on Tuesday . The company traded as high as $0.8932 and last traded at $0.8932. 5,000 shares changed hands during mid-day trading, a decline of 59% from the average session volume of 12,086 shares. The stock had previously closed at $0.8671.

Avacta Group Stock Up 3.0%

The business’s fifty day moving average is $0.85 and its 200 day moving average is $0.91.

Avacta Group Company Profile

Avacta Group plc is a UK-based biotechnology company specializing in the discovery, development and commercialization of Affimer® biotherapeutics and diagnostic reagents. The company’s proprietary Affimer platform uses small, engineered protein scaffolds that can be tailored to bind specifically to target molecules, offering an alternative to traditional antibodies. Avacta operates two core divisions: Avacta Therapeutics, which focuses on novel treatments in oncology and immune-related diseases, and Avacta Analytical, which develops reagents and point-of-care diagnostic tests.

In its diagnostics business, Avacta has applied the Affimer technology to lateral flow assays, most notably for rapid detection of viral pathogens such as SARS-CoV-2.